regulatory

Medtronic headquarters

Medtronic claims long-sought FDA approval in renal denervation

Medtronic claimed the FDA's second green light in renal denervation this month, as it competes with Recor for a potential multibillion-dollar market.

Conor Hale Nov 20, 2023 10:21am

FDA

FDA clears first OTC home antigen test for COVID-19. No, really

Nov 10, 2023 3:58pm

An illustration of ReCors renal denervation catheter

Recor claims 1st FDA renal denervation approval for hypertension

Nov 8, 2023 10:07am

heart art heart failure genes

Medtronic claims FDA nod for extravascular defibrillator implant

Oct 23, 2023 11:17am

Illumina hq

EU orders Illumina to split from Grail as penance for $8B deal

Oct 12, 2023 11:14am

FDA

FDA to form advisory committee for digital health and AI

Oct 11, 2023 2:27pm